Details

Autor(en) / Beteiligte

• Sliwa, Marcin
• Markovic, Darko
• Gabrusiewicz, Konrad
• Synowitz, Michael
• Glass, Rainer
• Zawadzka, Malgorzata
• Wesolowska, Aleksandra
• Kettenmann, Helmut
• Kaminska, Bozena

Titel

The invasion promoting effect of microglia on glioblastoma cells is inhibited by cyclosporin A

Ist Teil von

• Brain (London, England : 1878), 2007-02, Vol.130 (2), p.476-489

Ort / Verlag

Oxford: Oxford University Press

Erscheinungsjahr

2007

Link zum Volltext

Quelle

Oxford Journals 2020 Medicine

Beschreibungen/Notizen

• The invasion of tumour cells into brain tissue is a pathologic hallmark of WHO grades II–IV gliomas and contributes significantly to the failure of current therapeutic treatments. Activated microglial cells are abundant in brain tumours and may support tumour invasiveness. We have previously demonstrated that cyclosporin A (CsA) can affect growth of glioma cells in vitro by inhibiting signalling pathways, which are essential for tumour proliferation and invasiveness. In this work, we demonstrate that migration of EGFP-transfected glioblastoma cells in organotypic brain slices was significantly inhibited by treatment with CsA. On average 77% of untreated cells migrated beyond 500 μm, while only 28–33% cells migrated as far in the brain slices treated with CsA (P < 0.001). This inhibitory effect on glioblastoma invasion was lost when glioblastoma cells were injected into microglia-depleted brain slices. Moreover, CsA significantly inhibits intracranial glioma growth in vivo. We demonstrate that microglia-derived factors increase glioma invasiveness in Matrigel assay in vitro and this is associated with activation of the PI-3K/Akt signalling pathway. The invasion promoting effect of microglia is abolished in the presence of CsA. Furthermore, glioma-derived soluble factors induce morphological transformation of microglia and activate MAPK signalling, although production of pro-inflammatory factors was not observed. Our findings that CsA interferes at clinically relevant concentrations with the tumour-promoting role of microglia and impairs invasive growth of glioma cells in vivo may provide a novel therapeutic strategy against gliomas.